John Desimone reports a stock award at Herbalife

By AlphaYouPublished Nov 7, 2026Form 4

Stocks in this disclosure

Reported activity

DeSimone John

Reporting filer

John Desimone reports a stock award, not an open-market purchase or sale, in Herbalife Ltd.. Form 4 filed Nov 6, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Appreciation Rights (derivative)	DeSimone John	2026-11-04	A	Grant or award	34593	0	34,593	2 days	Filed terms security Title: Stock Appreciation Rights conversion Or Exercise Price: 15.31 id: F1 transaction Date: 2026-11-04 deemed Execution Date: transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 34593 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-11-04 underlying Security Title: Common Stock underlying Security Shares: 34593 shares Owned Following Transaction: 34593 direct Or Indirect Ownership: D

Owner: DeSimone John
Date: 2026-11-04
Code: A
Action: Grant or award
Quantity: 34593
Price: 0
Following holdings: 34,593
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Stock Appreciation Rights
conversion Or Exercise Price: 15.31
id: F1
transaction Date: 2026-11-04
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 34593
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-11-04
underlying Security Title: Common Stock
underlying Security Shares: 34593
shares Owned Following Transaction: 34593
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
DeSimone John: Interim CEO.
F1: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of November 4th, 2027, November 4th, 2028, and November 4th, 2029, subject to continued service through such date.

Prepared automatically from public filing data. Report a correction.